SUZHOU – November 03, 2026 -- CStone Pharmaceuticals (HKEX: 2616) will lead Phase I development of Kimia Therapeutics' potential first-in-class DNA damage response (DDR) cancer drug in mainland China and Australia, while Kimia reimburses the applicable clinical development costs.

SAN FRANCISCO – November 03, 2026 -- Thryv Therapeutics Inc. has raised a $30 million Series B financing led by InClin, Inc., a global contract research organization, to move its SGK1 inhibitor THRV-1268 into a Phase 2a heart failure study that opens for enrollment in early 2027.

The round follows completion of enrollment in the first efficacy cohort of the Wave II Phase 2/3 study of THRV-1268 in Long QT Syndrome. It also follows a favorable review of available Wave II data by the study's Independent Data Monitoring Committee (IDMC).

ATLANTA – November 03, 2026 -- Scientific Games will present its instant games, digital portfolio and retail technology at the World Lottery Summit in Sydney from November 9-12, targeting lottery executives, product managers and technologists from more than 75 countries.

Western Australia – November 02, 2026 -- Rio Tinto is pitching a portfolio of iron ore, copper and aluminium to investors as demand rises from AI, digital infrastructure and electrification, backed by operations in 35 countries and a workforce of more than 60,000.

DURHAM – November 02, 2026 -- Edinburgh-headquartered Abbott Risk Consulting (ARC) Ltd. has joined ISASecure, the certification program that validates conformance to the ISA/IEC 62443 series of cybersecurity standards for industrial automation and control systems (IACS), the International Society of Automation (ISA) announced.

London – November 02, 2026 -- Brightstar Lottery PLC (NYSE: BRSL) will debut eDraw Plus, a new iLottery game category, at the World Lottery Summit 2026 in Sydney, November 9-12. It is the company's first WLS appearance as a pure-play lottery business.

SYDNEY – November 02, 2026 -- Kazia Therapeutics (NASDAQ: KZIA) will present two preclinical abstracts on its lead asset paxalisib at the San Antonio Breast Cancer Symposium (SABCS), held Dec. 8-11, 2026, in San Antonio, Texas.

NEW YORK – November 02, 2026 -- SharonAI Holdings Inc. (NASDAQ: SHAZ) will release its third quarter 2026 financial results after the market closes on Monday, November 16, 2026. The Australian Neocloud provider will hold a conference call and webcast at 4:30 p.m. ET the same day to discuss the figures.

Perth – November 01, 2026 -- Orthocell Limited (ASX: OCC) sold 92 units of its Remplir nerve repair wrap in the U.S. in October 2026, generating AU$279,000 in revenue, an 84% increase on the average monthly sales of 50 units in Q1 FY27.

It is the strongest month of U.S. sales since the product launched. The company released the figures ahead of its Annual General Meeting on 6 November 2026. Standard quarterly reporting will continue after the meeting.

Singapore – October 30, 2026 -- Singapore Chief Justice Sundaresh Menon told judges that the closer artificial intelligence comes to exercising judgment, the greater the need for restraint, and that human judgment must stay central to the administration of justice.